American Regent et al., 2025-06-12: The label's overdosage section gives three dose bands: hypotension, wheezing and reduced oxygenation at single doses of 3 mg/kg or more; nausea, chest pain, dyspnoea, tachycardia, tremor, mild methemoglobinemia and ECG changes at a cumulative dose of 7 mg/kg or more; and severe intravascular haemolysis, hyperbilirubinemia and death at a single dose of 20 mg/kg or more.
Administration of large intravenous doses (cumulative dose ≥ 7 mg/kg ) of a methylene blue class product caused nausea, vomiting, precordial pain, dyspnea, tachypnea, chest tightness, tachycardia, apprehension, tremor, mydriasis, blue staining of the urine, the skin and mucous membranes, abdominal pain, dizziness, paresthesia, headache, confusion, mild methemoglobinemia (up to 7%) and electrocardiogram changes (T-wave flattening or inversion).
Section 10
American Regent et al., 2025-06-12: The label's overdosage section gives three dose bands: hypotension, wheezing and reduced oxygenation at single doses of 3 mg/kg or more; nausea, chest pain, dyspnoea, tachycardia, tremor, mild methemoglobinemia and ECG changes at a cumulative dose of 7 mg/kg or more; and severe intravascular haemolysis, hyperbilirubinemia and death at a single dose of 20 mg/kg or more. C5 core label figures – the "every stated maximum cumulative dose" element: (1) >=3 mg/kg single dose – hypotension, wheezing, reduced oxygenation; (2) >=7 mg/kg cumulative – the long adverse list quoted; (3) >=20 mg/kg single dose – severe intravascular haemolysis, hyperbilirubinemia, death. Separately, sections 2.1/14 state the maximum recommended number of doses is two at 1 mg/kg. Record field: label text transcribed as printed, including the spacing inside "( cumulative dose >= 7 mg/kg )" produced by the label's own markup. Read from the DailyMed HTML page. Also filed as MTF-34, MTO-47, MTF-33, MTO-51, MTA-28, MTA-24, MTB-49, MTF-01, MTO-52, MTO-45, MTJ-02, MTO-46, MTH-029, MTO-57, MTO-30, MTF-14, MTF-27, MTF-28, MTI-01, MTP-38, MTP-12, MTO-50, MTO-38, MTO-44, MTO-04, MTB-04, MTC-101, MTJ-28, MTF-20, MTD-025, MTH-041, MTI-05, MTB-30, MTD-102, MTF-41, MTO-21, MTO-22, MTF-17, MTB-48, MTF-52, MTB-13, MTB-40, MTB-47, MTB-58, MTD-101, MTC-077, MTD-098 (claims C1, C11, C13, C14, C2, C3, C4, C5, C6, C7, C8, C9, F1, F2, F3, F4, F5, F8). Study type: regulatory record.
